GBDC:NASDAQGolub Capital BDC, Inc. Analysis
Data as of 2026-06-11 - not real-time
$13.21
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock sits just above its short‑term moving average and slightly below its longer‑term averages, while the 14‑day momentum indicator hovers around the neutral zone. MACD has turned bullish, but the overall price trend remains bearish and the price is testing a key support level. Volatility is elevated and beta is low, suggesting price swings are pronounced but not strongly correlated with the broader market. Valuation signals: the price‑to‑earnings multiple is modestly higher than the industry average and the price‑to‑book ratio is below one, while the forward multiple looks more attractive. Dividend profile: the dividend yield is exceptionally high, but the payout ratio exceeds earnings, raising concerns about sustainability. Balance‑sheet stress: leverage is elevated with a debt‑to‑equity ratio far above peers and recent rating outlooks have shifted to negative due to thinning asset coverage.
Recent catalysts: Moody’s downgraded the outlook citing rising leverage; an analyst trimmed the price target; and the company priced a sizable senior note offering, adding to debt load. These developments, combined with a stable but modest trading volume, suggest caution. The market’s sentiment is bullish overall, yet the underlying fundamentals point to medium‑term risk and limited upside.
Recent catalysts: Moody’s downgraded the outlook citing rising leverage; an analyst trimmed the price target; and the company priced a sizable senior note offering, adding to debt load. These developments, combined with a stable but modest trading volume, suggest caution. The market’s sentiment is bullish overall, yet the underlying fundamentals point to medium‑term risk and limited upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish price trend near support
- negative rating outlook
- high dividend payout relative to earnings
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- forward earnings multiple suggests upside
- price close to book value
- potential price appreciation toward analyst targets
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- elevated leverage and debt burden
- unsustainable dividend policy
- sector headwinds for business development companies
Key Metrics & Analysis
Financial Health
Revenue Growth-12.00%
Profit Margin24.64%
P/E Ratio17.2
ROE5.26%
ROA4.66%
Debt/Equity125.46
P/B Ratio0.9
Op. Cash Flow$526.5M
Free Cash Flow$298.0M
Industry P/E16.5
Technical Analysis
TrendBearish
RSI52.9
Support$12.75
Resistance$13.49
MA 20$13.07
MA 50$13.12
MA 200$13.43
MACDBullish
VolumeStable
Fear & Greed Index84.13
Valuation
Target Price$13.75
Upside/Downside4.09%
GradeOvervalued
TypeValue
Dividend Yield10.90%
Risk Assessment
Beta0.60
Volatility20.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.